Skip to content

PRESS RELEASES


PRESS RELEASES

Date Title and Summary Additional Formats
Toggle Summary Integra LifeSciences Schedules Conference Call for Wednesday, February 27 to Discuss Fourth Quarter and Full Year 2001 Financial Results and Update Forward-Looking Financial Guidance
Integra LifeSciences Schedules Conference Call for Wednesday, February 27 to Discuss Fourth Quarter and Full Year 2001 Financial Results and Update Forward-Looking Financial Guidance PLAINSBORO, N.J. Feb. 20, 2002 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART) announced
View HTML
Toggle Summary Integra LifeSciences Reports Preliminary Fourth Quarter 2001 Revenues -- Product Sales Increase 26%; Full Financial Results to be Reported on February 27, 2002
Integra LifeSciences Reports Preliminary Fourth Quarter 2001 Revenues -- Product Sales Increase 26@Full Financial Results to be Reported on February 27, 2002 PLAINSBORO, N.J., Jan. 29, 2002 (PRIMEZONE) -- Led by strong growth in product sales, Integra LifeSciences Holdings Corporation (Nasdaq:
View HTML
Toggle Summary Integra LifeSciences to Present at the US Bancorp Piper Jaffray Health Care Conference
Integra LifeSciences to Present at the US Bancorp Piper Jaffray Health Care Conference PLAINSBORO, N.J., Jan 22, 2002 (BUSINESS WIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) announced today that it is scheduled to present at the US Bancorp Piper Jaffray Health Care Conference at
View HTML
Toggle Summary Integra NeuroSciences Direct Salesforce Begins Marketing Helitene Hemostatic Agent
Integra NeuroSciences Direct Salesforce Begins Marketing Helitene Hemostatic Agent PLAINSBORO, N.J., Jan 14, 2002 (BUSINESS WIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART) today announced that its Integra NeuroSciences division has begun marketing Helitene® Absorbable
View HTML
Toggle Summary FDA Panel Recommends rhBMP-2 Product Including Integra LifeSciences Absorbable Collagen Sponge
FDA Panel Recommends rhBMP-2 Product Including Integra LifeSciences Absorbable Collagen Sponge PLAINSBORO, N.J.--(BUSINESS WIRE)--Jan. 11, 2002--Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that the Orthopedic and Rehabilitation Devices Panel of the United States Food and
View HTML
Toggle Summary Integra LifeSciences Announces Acquisition of NeuroSupplies, Inc., a Specialty Distributor of Neurology Supplies
Integra LifeSciences Announces Acquisition of NeuroSupplies, Inc., a Specialty Distributor of Neurology Supplies PLAINSBORO, N.J., Dec 7, 2001 (BUSINESS WIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART) announced today that it has acquired NeuroSupplies, Inc., a specialty
View HTML
Toggle Summary Integra LifeSciences Reports Record Third Quarter Net Income on 31% Growth in Product Sales
Integra LifeSciences Reports Record Third Quarter Net Income on 31 PLAINSBORO, N.J., Nov 7, 2001 (BUSINESS WIRE) -- Operating Earnings Before Interest, Taxes, Depreciation and Amortization Totaled $5.4 Million Led by strong growth in product sales, Integra LifeSciences Holdings Corporation (Nasdaq:
View HTML
Toggle Summary Integra LifeSciences Schedules Conference Call for Wednesday, November 7 to Discuss Third Quarter 2001 Financial Results and Provide Forward-Looking Earnings Guidance
Integra LifeSciences Schedules Conference Call for Wednesday, November 7 to Discuss Third Quarter 2001 Financial Results and Provide Forward-Looking Earnings Guidance PLAINSBORO, N.J., Oct 31, 2001 (BUSINESS WIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) announced that it has
View HTML
Toggle Summary Integra LifeSciences to Present at the Techvest 3rd Annual Conference on Tissue Repair, Replacement and Regeneration
Integra LifeSciences to Present at the Techvest 3rd Annual Conference on Tissue Repair, Replacement and Regeneration PLAINSBORO, N.J.--(BUSINESS WIRE)--Oct. 18, 2001--Integra LifeSciences Holdings Corporation (NASDAQ:IART) announced today that it is scheduled to present at the Techvest 3rd Annual
View HTML
Toggle Summary Federal Judge Enters Final Post-Judgment Orders In Favor Of Integra Lifesciences -- Merck KGaA Held To Infringe Patents
Federal Judge Enters Final Post-Judgment Orders In Favor Of Integra Lifesciences -- Merck KGaA Held To Infringe Patents PLAINSBORO, N.J.--(BUSINESS WIRE)--Oct. 17, 2001--Integra LifeSciences Holdings Corporation (NASDAQ:IART) announced today that the United States District Court for the Southern
View HTML
Toggle Summary Integra NeuroSciences Announces New Product Launches at the Congress of Neurological Surgeons Meeting
Integra NeuroSciences Announces New Product Launches at the Congress of Neurological Surgeons Meeting PLAINSBORO, N.J., Oct 1, 2001 (BUSINESS WIRE) -- Integra NeuroSciences, the neurosurgical device division of Integra LifeSciences Holdings Corporation (Nasdaq:IART), today announced that it is
View HTML
Toggle Summary Integra LifeSciences Announces Conference Call for October 2, 2001 to Update Financial Outlook
Integra LifeSciences Announces Conference Call for October 2, 2001 to Update Financial Outlook PLAINSBORO, N.J., Sep 24, 2001 (BUSINESS WIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) announced today that it has scheduled a conference call for Tuesday, October 2, 2001 at 8:30 AM
View HTML
Toggle Summary Integra LifeSciences Announces Repayment of Bank Loans and Termination of Credit Facility
Integra LifeSciences Announces Repayment of Bank Loans and Termination of Credit Facility PLAINSBORO, N.J., Aug 23, 2001 (BUSINESS WIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) announced today that it has repaid in full $7.9 million of bank loans and terminated its $4.0 million
View HTML
Toggle Summary Integra LifeSciences Announces Investor Forum at the Congress of Neurological Surgeons Meeting on October 2, 2001
Integra LifeSciences Announces Investor Forum at the Congress of Neurological Surgeons Meeting on October 2, 2001 PLAINSBORO, N.J.--(BUSINESS WIRE)--Aug. 15, 2001--Integra LifeSciences Holdings Corporation (NASDAQ: IART) announced today that it has scheduled an Investor Forum at the Congress of
View HTML
Toggle Summary Integra LifeSciences Holdings Corporation Closes Public Offering of 5,060,000 Shares of Common Stock
Integra LifeSciences Holdings Corporation Closes Public Offering of 5,060,000 Shares of Common Stock PLAINSBORO, N.J., Aug 13, 2001 (BUSINESS WIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) announced today that it has closed its public offering of 5,060,000 shares of common stock
View HTML